🔗 Visit the ClinicalTrials.gov page for NCT01916577
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100. | Exp Hematol | 2009 | 1.26 |
| 2 | The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF. | Bone Marrow Transplant | 2010 | 1.19 |
| 3 | Targeted antagonism of CXCR4 mobilizes progenitor cells under investigation for cardiovascular disease. | Cytotherapy | 2009 | 0.78 |